Answers are grounded in this paper and cite their sources.
The CB2 cannabinoid receptor represents an attractive therapeutic target due to its immunomodulatory relevance and its lack of psychoactive effects. Here, we applied an integrated in silico approach to design and prioritize JWH-015-derived ligands with improved CB2 affinity and pharmacokinetic properties. Density functional theory calculations (PBE/TZVP/GEN-A2*) provided global and local reactivity descriptors that were correlated with predicted binding interactions obtained from a consensus docking strategy (AutoDock4, Vina, and Smina). Structural stability and interaction persistence were further assessed by nine 500-ns molecular dynamics simulations. Among the designed structures, analog 9 exhibited the most persistent and favorable interactions with key CB2 residues throughout the simulations, supporting its suitability as a lead candidate. In contrast, analogs 12 and 20 displayed notably safer biosafety profiles, indicating value as alternative scaffolds for further chemical exploration. These results support the rational design of CB2-targeted ligands and identify structural features that may guide future synthesis and biological evaluation.
No takes yet. Share an insight, caveat, or question.
Navarro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: